443956-55-6 Usage
General Description
"(2-Amino-5-bromopyridin-3-yl)methanol hydrobromide" is a chemical compound that belongs to the class of organic compounds called aminopyridines and derivatives. These are organic compounds containing an amino group attached to a pyridine ring. Pyridine is a six-membered ring with five carbon atoms and one nitrogen atom. The 5-bromopyridin-3-yl group indicates that a bromine atom is attached to the pyridine ring. The inclusion of methanol suggests a methyl and a hydroxyl group are attached, and hydrobromide means it forms interactions with a bromine ion. This substance is not commonly used, and its exact properties and impacts are not extensively researched. As with any chemical, it should be handled carefully to prevent unnecessary exposure and risks.
Check Digit Verification of cas no
The CAS Registry Mumber 443956-55-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,4,3,9,5 and 6 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 443956-55:
(8*4)+(7*4)+(6*3)+(5*9)+(4*5)+(3*6)+(2*5)+(1*5)=176
176 % 10 = 6
So 443956-55-6 is a valid CAS Registry Number.
InChI:InChI=1/C6H7BrN2O.BrH/c7-5-1-4(3-10)6(8)9-2-5;/h1-2,10H,3H2,(H2,8,9);1H
443956-55-6Relevant articles and documents
ANTIBIOTICS EFFECTIVE FOR GRAM-NEGATIVE PATHOGENS
-
Page/Page column 53; 55; 66-67, (2019/10/04)
Disclosed herein are antibacterial compounds that accumulate in Gram-negative bacteria, methods of preparing the compounds, and methods of using the compounds to inhibit or kill microbes, and methods of treating microbial infections, such as Gram-negative
ALKENYL COMPOUNDS AND METHODS OF USE
-
Paragraph 0285, (2014/12/12)
The present invention provides novel substituted alkenyl compounds, pharmaceutical acceptable salts and formulations thereof useful in modulating the protein tyrosine kinase activity, and in modulating cellular activities such as proliferation, differentiation, apoptosis, migration and invasion. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of hyperproliferative disorders in mammals, especially humans.
